Campañas contra el ocio y la vagancia.

1. Edwards, B.K., E. Ward, B.A. Kohler, et al., Annual report to the nation on the status of cancer, 1975-

2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer, 2010. 116(3): p. 544-73.

2. Winawer, S.J., A.G. Zauber, M.N. Ho, et al., Prevention of colorectal cancer by colonoscopic polypec-

tomy. The National Polyp Study Workgroup. N Engl J Med, 1993. 329(27): p. 1977-81.

3. Zauber, A.G., S.J. Winawer, M.J. O’Brien, et al., Colonoscopic polypectomy and long-term prevention

of colorectal-cancer deaths. N Engl J Med, 2012. 366(8): p. 687-96.

4. Kuipers, E.J., T. Rosch, and M. Bretthauer, Colorectal cancer screening—optimizing current strategies

and new directions. Nat Rev Clin Oncol, 2013. 10(3): p. 130-42.

5. Chen, S.C. and D.K. Rex, Endoscopist can be more powerful than age and male gender in predicting

adenoma detection at colonoscopy. Am J Gastroenterol, 2007. 102(4): p. 856-61.

6. European Colorectal Cancer Screening Guidelines Working, G., L. von Karsa, J. Patnick, et al.,

European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication. Endoscopy, 2013. 45(1): p. 51-9.

7. Halloran, S.P., G. Launoy, M. Zappa, et al., European guidelines for quality assurance in colorectal

cancer screening and diagnosis. First Edition—Faecal occult blood testing. Endoscopy, 2012. 44

Suppl 3: p. SE65-87.

8. Pohl, H. and D.J. Robertson, Colorectal cancers detected after colonoscopy frequently result from

missed lesions. Clin Gastroenterol Hepatol, 2010. 8(10): p. 858-64.

9. van Rijn, J.C., J.B. Reitsma, J. Stoker, et al., Polyp miss rate determined by tandem colonoscopy: a

systematic review. Am J Gastroenterol, 2006. 101(2): p. 343-50.

10. Pohl, H., A. Srivastava, S.P. Bensen, et al., Incomplete polyp resection during colonoscopy-results of

the complete adenoma resection (CARE) study. Gastroenterology, 2013. 144(1): p. 74-80 e1.

11. le Clercq, C.M. and S. Sanduleanu, Interval colorectal cancers: what and why. Curr Gastroenterol Rep, 2014. 16(3): p. 375.

12. Buchner, A.M., C. Guarner-Argente, and G.G. Ginsberg, Outcomes of EMR of defiant colorectal le-

sions directed to an endoscopy referral center. Gastrointest Endosc, 2012. 76(2): p. 255-63.

13. Khashab, M., E. Eid, M. Rusche, et al., Incidence and predictors of “late” recurrences after endoscopic

piecemeal resection of large sessile adenomas. Gastrointest Endosc, 2009. 70(2): p. 344-9.

14. Hol, L., M.E. van Leerdam, M. van Ballegooijen, et al., Screening for colorectal cancer: randomised

trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoid- oscopy. Gut, 2010. 59(1): p. 62-8.

15. van Roon, A.H., S.L. Goede, M. van Ballegooijen, et al., Random comparison of repeated faecal im-

munochemical testing at different intervals for population-based colorectal cancer screening. Gut,

2013. 62(3): p. 409-15.

16. Denters, M.J., M. Deutekom, P.M. Bossuyt, et al., Lower risk of advanced neoplasia among patients

with a previous negative result from a fecal test for colorectal cancer. Gastroenterology, 2012.

142(3): p. 497-504.

17. Winawer, S.J., A.G. Zauber, R.H. Fletcher, et al., Guidelines for colonoscopy surveillance after polypec-

tomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. Gastroenterology, 2006. 130(6): p. 1872-85.

18. Carney, P.A., J. O’Malley, D.I. Buckley, et al., Influence of health insurance coverage on breast, cervical,

19. Rey, J.F. and R. Lambert, Second look colonoscopy: indication and requirements. Dig Endosc, 2009.

21 Suppl 1: p. S47-9.

20. Rex, D.K., J.L. Petrini, T.H. Baron, et al., Quality indicators for colonoscopy. Gastrointest Endosc, 2006. 63(4 Suppl): p. S16-28.

21. Shah, H.A., L.F. Paszat, R. Saskin, et al., Factors associated with incomplete colonoscopy: a population-

based study. Gastroenterology, 2007. 132(7): p. 2297-303.

22. Hsu, C.M., W.P. Lin, M.Y. Su, et al., Factors that influence cecal intubation rate during colonoscopy in

deeply sedated patients. J Gastroenterol Hepatol, 2012. 27(1): p. 76-80.

23. Hautefeuille, G., J. Lapuelle, S. Chaussade, et al., Factors related to bowel cleansing failure before

colonoscopy: Results of the PACOME study. United European Gastroenterol J, 2014. 2(1): p. 22-9.

24. Froehlich, F., V. Wietlisbach, J.J. Gonvers, et al., Impact of colonic cleansing on quality and diagnostic

yield of colonoscopy: the European Panel of Appropriateness of Gastrointestinal Endoscopy European multicenter study. Gastrointest Endosc, 2005. 61(3): p. 378-84.

25. Hori, K., T. Uraoka, K. Harada, et al., Predictive factors for technically difficult endoscopic submucosal

dissection in the colorectum. Endoscopy, 2014.

26. Tholoor, S., O. Tsagkournis, P. Basford, et al., Managing difficult polyps: techniques and pitfalls. Ann Gastroenterol, 2013. 26(2): p. 114-121.

27. Digby, J., C.G. Fraser, F.A. Carey, et al., Faecal haemoglobin concentration is related to severity of

colorectal neoplasia. J Clin Pathol, 2013. 66(5): p. 415-9.

28. Ciatto, S., F. Martinelli, G. Castiglione, et al., Association of FOBT-assessed faecal Hb content with

colonic lesions detected in the Florence screening programme. Br J Cancer, 2007. 96(2): p. 218-21.

29. Rex, D.K., J.L. Petrini, T.H. Baron, et al., Quality indicators for colonoscopy. Am J Gastroenterol, 2006.

101(4): p. 873-85.

30. Rex, D.K., J.H. Bond, S. Winawer, et al., Quality in the technical performance of colonoscopy and the

continuous quality improvement process for colonoscopy: recommendations of the U.S. Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol, 2002. 97(6): p. 1296-308.

31. Vaananen, P. and R. Tenhunen, Rapid immunochemical detection of fecal occult blood by use of a

8